VAN ECK ASSOCIATES CORP – Regeneron Pharmaceuticals, Inc. Transaction History
VAN ECK ASSOCIATES CORP portfolio value:
$45.91M
portfolio value
VAN ECK ASSOCIATES CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.93% | 3.13K shares | 8.36M | $688.87 | 66.65K |
| Q2 2022 | share | Increase | +0.75% | 470 shares | -6.48M | $591.13 | 63.52K |
| Q1 2022 | share | Decrease | -3.43% | -2.24K shares | 2.80M | $698.42 | 63.05K |
| Q4 2021 | share | Increase | +7.91% | 4.78K shares | 4.61M | $642.51 | 65.29K |
| Q3 2021 | share | Decrease | -7.76% | -5.08K shares | -21K | $605.18 | 60.51K |
| Q2 2021 | share | Increase | +5.89% | 3.64K shares | 7.32M | $558.54 | 65.6K |
| Q1 2021 | share | Increase | +6.49% | 3.77K shares | 1.20M | $473.14 | 61.95K |
| Q4 2020 | share | Increase | +18.13% | 8.92K shares | 538K | $483.11 | 58.17K |
| Q3 2020 | share | Increase | +9.74% | 4.36K shares | -420K | $559.78 | 49.24K |
| Q2 2020 | share | Increase | +20.03% | 7.48K shares | 9.73M | $623.65 | 44.87K |
| Q1 2020 | share | Decrease | -27.20% | -13.96K shares | -1.02M | $488.29 | 37.38K |
| Q4 2019 | share | Decrease | -2.05% | -1.07K shares | 4.74M | $375.48 | 51.35K |
| Q3 2019 | share | Increase | +1.58% | 816 shares | -1.61M | $277.4 | 52.42K |
| Q2 2019 | share | Increase | +7.95% | 3.79K shares | -3.47M | $313 | 51.61K |
| Q1 2019 | share | Decrease | -9.87% | -5.23K shares | -179K | $410.62 | 47.81K |
| Q4 2018 | share | Decrease | -10.04% | -5.92K shares | -4.01M | $373.5 | 53.04K |
| Q3 2018 | share | Increase | +1.40% | 814 shares | 3.76M | $404.04 | 58.96K |
| Q2 2018 | share | Decrease | -4.77% | -2.91K shares | -965K | $344.99 | 58.15K |
| Q1 2018 | share | Decrease | -12.19% | -8.47K shares | -5.11M | $344.36 | 61.06K |
| Q4 2017 | share | Decrease | -3.87% | -2.79K shares | -6.2M | $375.96 | 69.54K |
| Q3 2017 | share | Increase | +8.15% | 5.45K shares | -506K | $447.12 | 72.34K |
| Q2 2017 | share | Decrease | -17.85% | -14.53K shares | 1.29M | $491.14 | 66.88K |
| Q1 2017 | share | Increase | +14.77% | 10.47K shares | 5.50M | $387.51 | 81.42K |
| Q4 2016 | share | Increase | +5.29% | 3.56K shares | -1.04M | $367.09 | 70.94K |
| Q3 2016 | share | Decrease | -2.75% | -1.90K shares | 2.89M | $402.02 | 67.37K |
| Q2 2016 | share | Increase | +1.89% | 1.28K shares | -314K | $349.23 | 69.27K |
| Q1 2016 | share | Increase | +10.21% | 6.30K shares | -8.98M | $360.44 | 67.99K |